Jarrett Jennie B, Lounsbery Jody L, D'Amico Frank, Dickerson Lori M, Franko John, Nagle John, Seehusen Dean A, Wilson Stephen A
University of Pittsburgh Medical Center St. Margaret Family Medicine Residency Program.
Fam Med. 2016 Mar;48(3):180-6.
The clinical pharmacist's role within family medicine residency programs (FMRPs) is well established. However, there is limited information regarding perceptions of program directors (PDs) about clinical pharmacy educators. The study objectives were (1) to estimate the prevalence of clinical pharmacists within FMRPs and (2) to determine barriers and motivations for incorporation of clinical pharmacists as educators.
The Council of Academic Family Medicine Educational Research Alliance (CERA) distributed an electronic survey to PDs. Questions addressed formalized pharmacotherapy education, clinical pharmacists in educator roles, and barriers and benefits of clinical pharmacists in FMRPs.
The overall response rate was 50% (224/451). Seventy-six percent (170/224) of the responding PDs reported that clinical pharmacists provide pharmacotherapy education in their FMRPs, and 57% (97/170) consider clinical pharmacists as faculty members. In programs with clinical pharmacists, 72% (83/116) of PDs reported having a systematic approach for teaching pharmacotherapy versus 22% (21/95) in programs without. In programs without clinical pharmacists, the top barrier to incorporation was limited ability to bill for clinical services 48% (43/89) versus 29% (32/112) in programs with clinical pharmacists. In both programs with and without clinical pharmacists, the top benefit of having clinical pharmacists was providing a collaborative approach to pharmacotherapy education for residents (35% and 36%, respectively).
Less than half of FMRPs incorporate clinical pharmacists as faculty members. Despite providing collaborative approaches to pharmacotherapy education, their limited ability to bill for services is a major barrier.
临床药师在家庭医学住院医师培训项目(FMRPs)中的作用已得到充分确立。然而,关于项目主任(PDs)对临床药学教育工作者看法的信息有限。本研究的目的是:(1)评估FMRPs中临床药师的比例;(2)确定将临床药师纳入教育工作者队伍的障碍和动机。
学术家庭医学教育研究联盟理事会(CERA)向项目主任发放了一份电子调查问卷。问题涉及正规的药物治疗教育、担任教育工作者角色的临床药师,以及临床药师在FMRPs中的障碍和益处。
总体回复率为50%(224/451)。76%(170/224)的回复项目主任报告称,临床药师在其FMRPs中提供药物治疗教育,57%(97/170)将临床药师视为教员。在有临床药师的项目中,72%(83/116)的项目主任报告有系统的药物治疗教学方法,而在没有临床药师的项目中这一比例为22%(21/95)。在没有临床药师的项目中,纳入临床药师的最大障碍是临床服务计费能力有限,占48%(43/89),而在有临床药师的项目中这一比例为29%(32/112)。在有和没有临床药师的项目中,有临床药师的最大益处都是为住院医师提供药物治疗教育的协作方法(分别为35%和36%)。
不到一半的FMRPs将临床药师纳入教员队伍。尽管临床药师为药物治疗教育提供了协作方法,但他们有限的服务计费能力是一个主要障碍。